458 related articles for article (PubMed ID: 18574508)
21. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
22. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
Kopko P; Silva M; Shulman I; Kleinman S
Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
[TBL] [Abstract][Full Text] [Related]
23. Recurrent transfusion-related acute lung injury after a two-year interval.
Krochmal JD; Dwyre DM; Swanson KM; Raife TJ; Schlueter AJ
Transfus Med; 2007 Jun; 17(3):192-6. PubMed ID: 17561861
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
Fontaine MJ; Malone J; Mullins FM; Grumet FC
Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
[TBL] [Abstract][Full Text] [Related]
25. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG
Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
[TBL] [Abstract][Full Text] [Related]
26. A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura.
P'ng SS; Hughes AS; Cooney JP
Ther Apher Dial; 2008 Feb; 12(1):78-81. PubMed ID: 18257817
[TBL] [Abstract][Full Text] [Related]
27. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
28. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008).
Eder AF; Herron RM; Strupp A; Dy B; White J; Notari EP; Dodd RY; Benjamin RJ
Transfusion; 2010 Aug; 50(8):1732-42. PubMed ID: 20456698
[TBL] [Abstract][Full Text] [Related]
29. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
[TBL] [Abstract][Full Text] [Related]
30. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
Mair DC; Hirschler N; Eastlund T
Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
[TBL] [Abstract][Full Text] [Related]
31. Patient-specific transfusion-related acute lung injury.
Muniz M; Sheldon S; Schuller RM; Young NS; Klein HG; Leitman SF; Stroncek DF
Vox Sang; 2008 Jan; 94(1):70-3. PubMed ID: 18171330
[TBL] [Abstract][Full Text] [Related]
32. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
Toy P; Hollis-Perry KM; Jun J; Nakagawa M
Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
[TBL] [Abstract][Full Text] [Related]
33. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
[TBL] [Abstract][Full Text] [Related]
34. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
35. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury.
Nishimura M; Takanashi M; Okazaki H; Satake M
Cell Biochem Funct; 2007; 25(2):179-83. PubMed ID: 16287215
[TBL] [Abstract][Full Text] [Related]
36. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related acute lung injury: past, present, and future.
Cherry T; Steciuk M; Reddy VV; Marques MB
Am J Clin Pathol; 2008 Feb; 129(2):287-97. PubMed ID: 18208810
[TBL] [Abstract][Full Text] [Related]
38. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
[TBL] [Abstract][Full Text] [Related]
39. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.
Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H
Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244
[TBL] [Abstract][Full Text] [Related]
40. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
